Page 32 - E-MODUL PEMERIKSAAN RUJUKAN PRODIA
P. 32

Antiphospholipid Antibody Panel


                        14890
                        Test Components:
                        7352    Cardiolipin Antibodies (IgA, IgG, IgM)
                        10062 Phosphatidylserine Antibodies (IgG, IgA, IgM)
                        CPT Code(s): 86146 (x3), 86147 (x3), 86148 (x3)
                        Includes
                        Beta-2-Glycoprotein I Antibodies (IgG, IgA, IgM)
                        Phosphatidylserine Antibodies (IgG, IgA, IgM)
                        Cardiolipin Antibodies (IgA, IgG, IgM)

                        Preferred Specimen(s) : 5 mL plasma collected in a 3.2% sodium citrate
                        (light blue-top) tube
                        Minimum Volume : 3 mL
                        Alternate Specimen(s) : Serum
                        Instructions
                        Plasma (preferred): Centrifuge light blue-top tube 15 minutes at
                        approximately 1500 x g within 60 minutes of collection. Using a plastic
                        pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer
                        and place into a plastic vial. Centrifuge a second time and transfer
                        platelet-poor plasma into a new plastic vial. Plasma must be free of
                        platelets (<10,000/mcL).


                        Serum: Centrifuge red-top tube 15 minutes at approximately 1500 x g
                        within 24 hours of collection. Transfer serum into a plastic specimen vial.
                        Room temperature
                        Specimen Stability : Room temperature: 4 days , Refrigerated: 7 days
                        Frozen: 28 days . Reject Criteria : Gross hemolysis • Grossly lipemic

                        Methodology : Immunoassay (IA)


                        Clinical Significance
                        The Antiphospholipid Antibody Syndrome (APS) is a clinical-pathologic
                        correlation that includes a clinical event (e.g., thrombosis, pregnancy loss,
                        thrombocytopenia) and persistent positive Antiphospholipid Antibodies
                        (IgM or IgG ACA >40 MPL/GPL, IgM or IgG anti-B2GPI antibodies, or a
                        Lupus Anticoagulant). The IgA isotype has been implicated in smaller
                        studies, but has not yet been incorporated into the APS criteria.
                        International consensus guidelines suggest waiting at least 12 weeks
                        before retesting to confirm antibody persistence. Reference J Thromb
                        Haemost 2006: 4; 295.
                        (The CPT codes provided are based on AMA guidelines and are for
                        informational purposes only. CPT coding is the sole responsibility of the
                        billing party. Please direct any questions regarding coding to the payer
                        being billed.)


                                                              31
   27   28   29   30   31   32   33   34   35